Francesca Romana Gallo Selected Research

voacamine

1/2022	A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells.
6/2020	Voacamine: Alkaloid with its essential dimeric units to reverse tumor multidrug resistance.
11/2015	High-performance thin-layer chromatography for the evaluation of voacamine intracellular concentration related to its cytotoxic effect.
4/2014	Voacamine modulates the sensitivity to doxorubicin of resistant osteosarcoma and melanoma cells and does not induce toxicity in normal fibroblasts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesca Romana Gallo Research Topics

Disease

3	Neoplasms (Cancer) 01/2022 - 04/2014
3	Osteosarcoma (Osteogenic Sarcoma) 06/2020 - 04/2014
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Melanoma (Melanoma, Malignant) 04/2014

Drug/Important Bio-Agent (IBA)

4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 04/2014
4	voacamineIBA 01/2022 - 04/2014
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022 - 04/2014
2	Pharmaceutical PreparationsIBA 01/2022 - 04/2014
2	AlkaloidsIBA 06/2020 - 04/2014
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Biological ProductsIBA 01/2022
1	vobasineIBA 06/2020
1	voacangineIBA 06/2020

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2022
1	Therapeutics 04/2014